Blogs
- All
- About us
- Campaigning
- Dementia info
- Fundraising
- Living with dementia
- Our scientists
- Our supporters
- Research
How we calculated our ‘one in two’ dementia statistic – and what we’ll do about it
It’s news no one wants to hear, but our new analysis, released today, has estimated if nothing changes, one in two people will be directly affected by dementia. They will either care for someone with the condition, develop it themselves, or both. Read our blog to find out more.
The outlook for dementia is changing, and so are we
Our Chief Executive Hilary Evans reflects on the changing outlook for dementia research, and why it’s time to strive for a cure.
Dementia will be part of my future – but I know research will find a cure
Supporter Jordan Adams shares why he’s so positive that research will find a cure and end the heartbreak of dementia.
Five things we’ve learnt about the nation’s brain health
This Dementia Action Week, we look back at what we’ve learnt from the Think Brain Health Check-in so far – and the actions people are taking to protect their brains.
Why we’re calling for stricter air pollution targets to tackle dementia risk
With dementia now recognised as the leading cause of death in the UK, we urgently need tighter measures on air pollution to help reduce the number of people living with dementia in the future. That’s why Alzheimer’s Research UK is calling on the UK government to lead from the front in reducing air pollution on a national level.
New Alzheimer’s drug, donanemab – what is it and how does it work?
Donanemab – Answers to some of the most commonly asked questions to our Dementia Research Infoline and across our social media channels.
The big brain health check-in – your top questions answered
Following the launch of our Think Brain Health Check-in, we answer some of your top brain health questions.
Six highlights from Alzheimer’s Research UK Conference 2023
More than 500 researchers got together in person and online at the P&J Live, Aberdeen, for Alzheimer’s Research UK’s Conference 2023, the UK’s largest dementia research conference. Read our six highlights from the conference
Levelling the playing field: why inclusivity matters in dementia research
Science is not immune to gaps in inclusivity, and dementia research is no exception. In one respect, inclusivity in research means paying attention to representation in scientific studies, for example recruiting people from diverse backgrounds into clinical research studies or using both male and female animals in experiments. But it goes beyond that – it…
Five Slimming World members get set to run the London Marathon in aid of dementia research
Five members from Slimming World have shared their inspiring stories with us, touching on the people who inspire them to run 26 miles and raise £2,500 for dementia research.
How The Perfume Shop raised £1 MILLION for Alzheimer’s Research UK
Our long-term partner, The Perfume Shop, reached a phenomenal fundraising milestone of £1 million at the end of 2022. Managing Director, Gill Smith, shares her highlights in our latest blog.
The government’s ‘Major Conditions Strategy’ must deliver for people with dementia
The government’s new ‘Major Conditions Strategy’ – albeit light on detail and fanfare – signals a new direction for people with dementia and their families. Our Director of Policy & Public Affairs explains what we want this strategy to deliver.
Introducing the Check-in, a tool for better brain health
Our Chief Executive Hilary Evans explains why we’re optimistic that the new Think Brain Health Check-in will help thousands take small steps towards better brain health.
Kirsty Gallacher: I’ve checked-in on my brain health, now it’s your turn
Having seen the impact of dementia on her grandfather, TV and radio presenter Kirsty Gallacher is on a mission to get people to check in on their brain health and help reduce their risk of dementia.
Understanding your barriers to brain healthy habits – and how to overcome them
Building new habits is a journey and obstacles are to be expected. Samuel Salzer explains how we can overcome them.
6 top tips for setting brain healthy habits that stick
Ready to set a new brain healthy habit? Read behavioural scientist Samuel Salzer’s top tips.
Blood pressure and brain health: what’s the link?
Let’s dig into the research to explore what we know about the way our blood pressure affects the brain’s ability to function.
Why keeping connected is so important – and where to start
Most of us know that keeping connected is important for our emotional health. But research tells us that social connections can help keep our brains healthy too.
What should we eat for a healthy brain?
Prof Anne Marie Minihane explores how what we eat impacts our brains – and discusses her team’s research to find more answers.
Solving a 30-year mystery – how an important Alzheimer’s risk gene affects our brain
Lots of factors affect a person’s risk of getting Alzheimer’s disease, the number one cause of dementia. It’s a complex mix of lifestyle, health and age, but our genetic makeup plays a particularly important role in determining whether we will get Alzheimer’s.
How does our mental wellbeing affect our brain health?
Much of my research looks at how mental health and brain health are connected – but first, let’s explore how these two things are different.
5 things that might surprise you about brain health
We live in an age where information has never been easier to find, or harder to trust. When it comes to brain health, separating fact from fiction isn’t always easy – so let’s examine some common myths and put the record straight.
“It’s hard not to see it as anything other than momentous” – our CEO reflects on a year of progress
It’s been a difficult year for so many of us, with a fraught economic climate, political uncertainty, and highs and lows of all sorts – not least the temperature. And in the aftermath of the pandemic, continued pressure on the NHS and social care have made life incredibly tough, particularly for many people affected by…
New Alzheimer’s treatment, lecanemab, makes the headlines: what’s next?
December 2022 saw the release of clinical trial results investigating a potential new Alzheimer’s treatment called lecanemab – the first drug that slows down the physical progression of the disease, and also symptom progression. We have compiled your most commonly asked questions and some answers about this historic news
